MedTrace Logo

Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors [The Daily D Health Study]

NCT01537809 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 691

Last updated 2013-12-13

No results posted yet for this study

Summary

The purpose of this research is to determine what supplemental doses of vitamin D may be necessary to raise serum levels to optimal levels and how vitamin D supplementation and changes in vitamin D status impact cardiovascular risk factors in schoolchildren.

Conditions

  • Vitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

Subjects are told to take vitamin D daily for 6 months.

DIETARY_SUPPLEMENT

Vitamin D3

Subjects are asked to take vitamin D orally, daily for six months.

Sponsors & Collaborators

  • Office of Dietary Supplements (ODS)

    collaborator NIH

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Boston University

    collaborator OTHER

  • Boston Children's Hospital

    collaborator OTHER

  • Tufts University

    lead OTHER

Principal Investigators

  • Jennifer Sacheck, PhD · Tufts University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01537809 on ClinicalTrials.gov